Merge Labs

A new brain-computer interface startup has launched with the stated aim of competing with Merge Labs, the neurotechnology venture backed by OpenAI chief executive Sam Altman. The company, covered by Wired, enters a field where Altman's venture has drawn attention for its ambitions around merging human cognition with artificial intelligence. The launch signals growing investor interest in neurotech as a next frontier in the AI race.

A new neurotechnology startup has launched with the stated aim of competing with Merge Labs, the brain-computer interface company backed by Sam Altman. Details of the new company, including its founders and funding, are sparse so far. The move signals growing competition in the consumer neurotech space, where Altman's venture is among several pursuing brain-computer interfaces.

A new neurotechnology startup has launched with the stated aim of competing with Merge Labs, the brain-computer interface company backed by Sam Altman. The venture, covered by Wired, enters a field where Altman's company is pursuing mind-machine interfaces alongside rivals like Neuralink. Details on the startup's founders, funding and technology remain limited, but its arrival signals growing investor interest in neurotech.

Bridge Neurotech has emerged as a new competitor to Merge Labs, the brain-computer interface startup backed by OpenAI chief executive Sam Altman. The company joins a growing field of ventures working on neural interfaces, a space long dominated by Elon Musk's Neuralink. Attention is focused on how the new entrant's technology and funding compare with Altman's venture.